Align Technology | ALGN - Ebitda


Align Technology reported $229.14M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
3M USD 1.66B 239M Jun/2026
Align Technology USD 229.14M 31.74M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Cardinal Health USD 955M 135M Jun/2026
Charles River Laboratories USD 272.95M 43.14M Jun/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
CVS Health USD 5.85B 25M Jun/2026
Danaher USD 1.84B 81M Jun/2026
Dentsply International USD 190M 61M Jun/2026
Dexcom USD 364.5M 57.7M Mar/2026
Henry Schein USD 288M 1000K Jun/2026
Idexx Laboratories USD 468.46M 67.59M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
IQVIA Holdings USD 994M 62M Jun/2026
McKesson USD 1.71B 674M Jun/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
Solventum Corp USD 670M 233M Jun/2026
Stryker USD 1.93B 357M Jun/2026
Teleflex USD 75.63M 171.44M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Veeva Systems USD 403.96M 29.17M Mar/2026
Waters USD 712M 545M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026
Zoetis USD 939M 0 Mar/2026